These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies. Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Sarangarajan R; Rajagopalan R; Cayanis E; Edelman IS; Penn AS Immunol Rev; 1986 Dec; 94():23-37. PubMed ID: 3492425 [No Abstract] [Full Text] [Related]
25. Myasthenia gravis. De Baets MH Year Immunol; 1989-1990; 6():269-75. PubMed ID: 2701909 [No Abstract] [Full Text] [Related]
26. Anti-receptor antibodies: a fascinating new concept in clinical medicine. Williams RC Minn Med; 1982 Mar; 65(3):173-6. PubMed ID: 7087954 [No Abstract] [Full Text] [Related]
27. [Cell surface receptors and their disorders]. Bergström K; Boberg J; Dahlberg PA; Hall K; Johansson SG; Karlsson A; Smith U; Wiman K Lakartidningen; 1981 Mar; 78(13):1309-18. PubMed ID: 6261050 [No Abstract] [Full Text] [Related]
28. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)]. Hohlfeld R; Wekerle H MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965 [TBL] [Abstract][Full Text] [Related]
29. [Anti-TSH receptor antibodies and autoimmune thyroid diseases]. Ichikawa Y; Arikawa K; Yoshida T; Suzuki Y; Kawai S Horumon To Rinsho; 1983 Dec; 31(12):1185-90. PubMed ID: 6323060 [No Abstract] [Full Text] [Related]
30. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome]. Andreis I; Lovnićki TJ; Beara N; Taradi M Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205 [TBL] [Abstract][Full Text] [Related]
32. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries. Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546 [TBL] [Abstract][Full Text] [Related]
33. Autoimmune disease and the nervous system. Steinman L West J Med; 1992 Jun; 156(6):664-6. PubMed ID: 1615671 [No Abstract] [Full Text] [Related]
34. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors. Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141 [TBL] [Abstract][Full Text] [Related]
35. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Toth C; McDonald D; Oger J; Brownell K Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036 [TBL] [Abstract][Full Text] [Related]
36. Lymphocyte activation in experimental autoimmune myasthenia gravis. De Baets MH; Einarson B; Lindstrom JM; Weigle WO J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589 [No Abstract] [Full Text] [Related]
37. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis. Claudio T; Raftery MA J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372 [TBL] [Abstract][Full Text] [Related]
38. [Antibodies in myasthenia gravis]. Eymard B Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288 [TBL] [Abstract][Full Text] [Related]
39. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Kawanami S; Tsuji R; Oda K Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620 [TBL] [Abstract][Full Text] [Related]
40. [Physiopathology of myasthenia gravis. A review (author's transl)]. Bergmans J Ann Chir; 1980 Mar; 34(3):147-57. PubMed ID: 6245616 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]